RBC Capital Reiterates Outperform on Varonis Systems, Maintains $31 Price Target

RBC Capital analyst Matthew Hedberg reiterates Varonis Systems (NASDAQ:VRNS) with a Outperform and maintains $31 price target.

byBenzinga Newsdesk

March 15, 2023

1 minute read

RBC Capital analyst Matthew Hedberg reiterates Varonis Systems (NASDAQ:VRNS) with a Outperform and maintains $31 price target.

Why Are ChemoCentryx’s Shares Trading Higher Today?

By Vandana Singh

Today, 12:33 PM

ChemoCentryx Inc’s (NASDAQ:CCXI) partner Kissei Pharmaceutical Co Ltd has received approval from the Japanese Ministry of Health, Labor, and Welfare (MHLW) to market…

CCXI

HOOKIPA Pharma Q2 EPS $(0.23) Beats $(0.36) Estimate, Sales $2.75M Miss $3.56M Estimate

By Benzinga Newsdesk

Today, 12:33 PM

HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.36) by 36.11 percent. This is a 55.77 percent increase over losses of $(0.52) per share from

HOOK

RBC Capital Initiates Coverage On Wayfair with Sector Perform Rating, Announces Price Target of $158

By Benzinga Newsdesk

Today, 12:33 PM

RBC Capital analyst Steven Shemesh initiates coverage on Wayfair (NYSE:W) with a Sector Perform rating and announces Price Target of $158.

United Airlines Earnings Preview: What The Street Is Expecting, And What The Options Flow Says

By AJ Fabino

Today, 12:33 PM

The airline sector's earnings season got off to a strong start last week when Delta Air Lines Inc. (NYSE: DAL) issued optimistic guidance as business and international travel began to pick up

DAL

RBC Capital Reiterates Outperform on Varonis Systems, Maintains $31 Price Target

Related Posts

Why Are ChemoCentryx’s Shares Trading Higher Today?

HOOKIPA Pharma Q2 EPS $(0.23) Beats $(0.36) Estimate, Sales $2.75M Miss $3.56M Estimate

RBC Capital Initiates Coverage On Wayfair with Sector Perform Rating, Announces Price Target of $158

United Airlines Earnings Preview: What The Street Is Expecting, And What The Options Flow Says